Filing Details
- Accession Number:
- 0001628280-25-004076
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-02-05 16:44:27
- Reporting Period:
- 2025-02-03
- Filing Date:
- 2025-02-05
- Accepted Time:
- 2025-02-05 16:44:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1104506 | Insmed Inc | INSM | Pharmaceutical Preparations (2834) | 541972729 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1402051 | William Lewis | 700 Us Highway 202/206 Bridgewater NJ 08807 | Chair And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-02-03 | 18,750 | $22.76 | 398,284 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-02-03 | 241 | $75.25 | 398,043 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-03 | 1,872 | $76.35 | 396,171 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-03 | 9,869 | $77.97 | 386,302 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-02-03 | 6,768 | $78.44 | 379,534 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2025-02-03 | 6,830 | $10.85 | 240,754 | No | 4 | M | Indirect | By the Katie Procter Dynasty Trust |
| Common Stock | Disposition | 2025-02-03 | 41 | $74.86 | 240,713 | No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
| Common Stock | Disposition | 2025-02-03 | 745 | $76.43 | 239,968 | No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
| Common Stock | Disposition | 2025-02-03 | 3,463 | $77.95 | 236,505 | No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
| Common Stock | Disposition | 2025-02-03 | 2,581 | $78.40 | 233,924 | No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Indirect | By the Katie Procter Dynasty Trust |
| No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
| No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
| No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
| No | 4 | S | Indirect | By the Katie Procter Dynasty Trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2025-02-03 | 18,750 | $0.00 | 18,750 | $22.76 |
| Common Stock | Stock Option (right to buy) | Disposition | 2025-02-03 | 6,830 | $0.00 | 6,830 | $10.85 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 56,250 | 2025-05-21 | No | 4 | M | Direct | |
| 211,800 | 2026-05-19 | No | 4 | M | Indirect |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 50,500 | Indirect | By the William Lewis Family Legacy Trust |
Footnotes
- This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- This is the weighted average sales price representing 241 shares sold at prices ranging from $74.86 to $75.83 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 1,872 shares sold at prices ranging from $76.00 to $76.57 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 9,869 shares sold at prices ranging from $77.29 to $78.28 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 6,768 shares sold at prices ranging from $78.31 to $78.80 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 745 shares sold at prices ranging from $76.10 to $76.90 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 3,463 shares sold at prices ranging from $77.24 to $78.23 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- This is the weighted average sales price representing 2,581 shares sold at prices ranging from $78.26 to $78.75 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
- The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable.
Billionaire Hedge Funds
